Respiratory allergic diseases and allergen immunotherapy: A French patient survey before and during the COVID-19 pandemic.

ABSTRACT:

Background

The COVID-19 pandemic brought unprecedented global disruption to both healthcare providers and patients with respiratory allergies. There are limited real-life data on the impact of the COVID-19 pandemic on the risk perception of patients with allergy treated with allergen immunotherapy (AIT).

Objective

To understand the risk perception of allergic patients treated with sublingual immunotherapy (SLIT) before and during the pandemic, and their attitudes towards COVID-19 infection and vaccination.

Methods

This was a non-interventional, cross-sectional survey conducted from October to November 2021 in France. Adult patients, who had been prescribed and had received a Stallergenes SLIT (liquid or liquid and tablets) before the pandemic (from August 1, 2018 to M

SUBMITTER: Devillier P 

PROVIDER: S-EPMC11017353 | biostudies-literature | 2024 Apr

REPOSITORIES: biostudies-literature